Table 3.
Multivariable-adjusted* hazard ratios (HRs) and 95% confidence intervals (CIs) for ischemic vascular events among women with active migraine according to migraine features in the Women’s Health Study (N=27,840)
| No migraine history (N=22,715) | Active migraine with aura (N=1,434) | P value | Active migraine without aura (N=2,176) | P value | Prior migraine (N=1,515) | P value | |
|---|---|---|---|---|---|---|---|
| Major Cardiovascular Event † | N=567 | N=54 | N=39 | N=48 | |||
| Overall | 1.00 | 2.01 (1.52–2.67) | <0.0001 | 1.04 (0.75–1.44) | 0.81 | 1.13 (0.84–1.52) | 0.41 |
| Attack duration of 4–72 hours | |||||||
| Yes | ——— | 2.11 (1.53–2.89) | <0.0001 | 0.98 (0.67–1.44) | 0.93 | ——— | — |
| No | 1.74 (0.98–3.09) | 0.06 | 1.22 (0.67–2.22) | 0.51 | |||
| Unilateral pain location | |||||||
| Yes | ——— | 2.05 (1.43–2.96) | 0.0001 | 0.87 (0.54–1.40) | 0.57 | ——— | — |
| No | 1.96 (1.29–2.97) | 0.002 | 1.24 (0.80–1.93) | 0.33 | |||
| Photophobia | |||||||
| Yes | ——— | 1.87 (1.33–2.61) | 0.0003 | 1.00 (0.66–1.51) | 0.99 | ——— | — |
| No | 2.42 (1.49–3.93) | 0.0003 | 1.11 (0.67–1.87) | 0.68 | |||
| Phonophobia | |||||||
| Yes | ——— | 1.85 (1.19–2.86) | 0.006 | 0.85 (0.50–1.46) | 0.56 | ——— | — |
| No | 2.13 (1.50–3.04) | <0.0001 | 1.18 (0.79–1.77) | 0.41 | |||
| Nausea/vomiting | |||||||
| Yes | ——— | 1.64 (1.12–2.40) | 0.01 | 1.00 (0.66–1.51) | 0.99 | ——— | — |
| No | 2.66 (1.79–3.94) | <0.0001 | 1.11 (0.66–1.85) | 0.70 | |||
| Pulsating pain quality | |||||||
| Yes | ——— | 1.93 (1.30–2.86) | 0.001 | 0.58 (0.32–1.02) | 0.06 | ——— | — |
| No | 2.09 (1.43–3.07) | 0.0002 | 1.62 (1.10–2.38) | 0.02 | |||
| Aggravation by physical activity | |||||||
| Yes | ——— | 1.73 (1.01–2.95) | 0.04 | 0.78 (0.42–1.46) | 0.43 | ——— | — |
| No | 2.13 (1.54–2.95) | <0.0001 | 1.18 (0.81–1.71) | 0.40 | |||
| Ischemic stroke | N=257 | N=22 | N=17 | N=16 | |||
| Overall | 1.00 | 1.79 (1.15–2.78) | 0.01 | 1.01 (0.61–1.65) | 0.98 | 0.82 (0.50–1.36) | 0.45 |
| Attack duration of 4–72 hours | |||||||
| Yes | ——— | 1.64 (0.97–2.77) | 0.06 | 1.17 (0.69–1.97) | 0.57 | ——— | — |
| No | 2.22 (1.05–4.72) | 0.04 | 0.50 (0.12–2.00) | 0.33 | |||
| Unilateral pain location | |||||||
| Yes | ——— | 1.42 (0.75–2.68) | 0.28 | 0.75 (0.35–1.59) | 0.45 | ——— | — |
| No | 2.28 (1.28–4.08) | 0.006 | 1.32 (0.70–2.49) | 0.39 | |||
| Photophobia | |||||||
| Yes | ——— | 1.43 (0.82–2.51) | 0.21 | 1.12 (0.62–2.00) | 0.71 | ——— | — |
| No | 2.80 (1.44–5.46) | 0.003 | 0.81 (0.33–1.97) | 0.64 | |||
| Phonophobia | |||||||
| Yes | ——— | 1.34 (0.63–2.85) | 0.44 | 0.55 (0.20–1.48) | 0.24 | ——— | — |
| No | 2.12 (1.25–3.58) | 0.005 | 1.35 (0.77–2.36) | 0.30 | |||
| Nausea/vomiting | |||||||
| Yes | ——— | 0.91 (0.43–1.93) | 0.80 | 1.20 (0.68–2.11) | 0.52 | ——— | — |
| No | 3.27 (1.93–5.51) | <0.0001 | 0.66 (0.25–1.77) | 0.41 | |||
| Pulsating pain quality | |||||||
| Yes | ——— | 1.66 (0.88–3.13) | 0.12 | 0.85 (0.42–1.73) | 0.66 | ——— | — |
| No | 1.92 (1.07–3.43) | 0.03 | 1.20 (0.61–2.34) | 0.60 | |||
| Aggravation by physical activity | |||||||
| Yes | ——— | 1.61 (0.71–3.62) | 0.25 | 1.05 (0.46–2.36) | 0.91 | ——— | — |
| No | 1.87 (1.13–3.11) | 0.02 | 0.98 (0.54–1.81) | 0.96 | |||
| Myocardial infarction | N=243 | N=25 | N=17 | N=20 | |||
| Overall | 1.00 | 2.11 (1.39–3.21) | 0.0004 | 1.01 (0.62–1.66) | 0.96 | 1.08 (0.68–1.70) | 0.74 |
| Attack duration of 4–72 hours | |||||||
| Yes | ——— | 2.26 (1.42–3.59) | 0.0006 | 0.86 (0.47–1.57) | 0.62 | ——— | — |
| No | 1.68 (0.69–4.08) | 0.25 | 1.51 (0.67–3.41) | 0.32 | |||
| Unilateral pain location | |||||||
| Yes | ——— | 2.26 (1.34–3.83) | 0.002 | 0.97 (0.50–1.90) | 0.93 | ——— | — |
| No | 1.93 (1.02–3.64) | 0.04 | 1.06 (0.53–2.16) | 0.86 | |||
| Photophobia | |||||||
| Yes | ——— | 2.39 (1.52–3.76) | 0.0002 | 1.00 (0.55–1.84) | 0.99 | ——— | — |
| No | 1.32 (0.49–3.56) | 0.58 | 1.03 (0.46–2.33) | 0.94 | |||
| Phonophobia | |||||||
| Yes | ——— | 2.14 (1.16–3.93) | 0.01 | 1.07 (0.52–2.16) | 0.86 | ——— | — |
| No | 2.10 (1.22–3.61) | 0.008 | 0.97 (0.50–1.89) | 0.92 | |||
| Nausea/vomiting | |||||||
| Yes | ——— | 1.98 (1.17–3.36) | 0.01 | 1.02 (0.55–1.87) | 0.95 | ——— | — |
| No | 2.35 (1.24–4.43) | 0.009 | 1.00 (0.44–2.25) | 0.99 | |||
| Pulsating pain quality | |||||||
| Yes | ——— | 1.81 (0.98–3.32) | 0.06 | 0.32 (0.10–1.00) | 0.05 | ——— | — |
| No | 2.43 (1.41–4.18) | 0.001 | 1.88 (1.09–3.23) | 0.02 | |||
| Aggravation by physical activity | |||||||
| Yes | ——— | 1.40 (0.58–3.42) | 0.46 | 0.51 (0.16–1.60) | 0.25 | ——— | — |
| No | 2.42 (1.53–3.83) | 0.0002 | 1.28 (0.74–2.20) | 0.38 | |||
controlling for: age, body mass index, diabetes, physical activity, postmenopausal hormone use, oral contraceptive use, history of hypertension, alcohol consumption, smoking, family history of premature myocardial infarction, LDL levels, HDL levels.
A major cardiovascular event was defined as the first of any of these events: nonfatal ischemic stroke, nonfatal myocardial infarction, or death from ischemic cardiovascular cause.